EUVIMEDEUVIMED entdecken
Fallbericht

TRAF7 ‐Mutated Myxoid and Spindle Cell Mesenchymal Tumor Occurring in a Pediatric Patient in the Post‐Transplant Setting: Expanding the Spectrum of TRAF7 ‐Mutated Tumors

Stephanie Torres, Zachary High, Qian Wang iD, Clinton Piper, Erika Friehling, Brian Feingold, Ivy John iD, Marcus Malek iD, Armando Ganoza, John M Skaugen, Catherine K Gestrich

Genes, Chromosomes and Cancer · 2025

DOI: 10.1002/gcc.70092 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Genes, Chromosomes and Cancer, 2025. Verfasst von Stephanie Torres und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Tumor Necrosis Factor Receptor-Associated Peptides and Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TRAF7 mutations have been reported in many tumor types, including subsets of meningiomas, mesothelioma, intraneural perineuriomas, and rare cases of aggressive fibromyxoid spindle cell tumors in adults. We expand the spectrum of TRAF7 ‐mutated tumors by reporting a case of a TRAF7 ‐mutated myxoid and spindle cell mesenchymal tumor in a 13‐year‐old female with a history of a heart and renal transplant. Histopathologic examination demonstrated hypocellular areas composed of bland spindle cells in a myxoid matrix and hypercellular areas with significant pleomorphism and up to 13 mitotic figures per 10 high‐power fields. The spindle cells were positive for CD34 and negative for smooth muscle actin (SMA) and S100. Whole exome sequencing identified a TRAF7 p.S561R mutation. Methylation profiling illustrated that the tumor did not embed within a distinct tumor group. The tumor was resected, and the patient remains stable at 7 months follow‐up. This report is the first known case of a TRAF7 ‐mutated myxoid and spindle cell tumor in a pediatric patient.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Necrosis Factor Receptor-Associated Peptides and ProteinsHumansFemaleAdolescentMutationKidney TransplantationExome Sequencing

Stichwörter der Autor:innen

TRAF7pediatricsarcoma

Substanzen

TRAF7 protein, humanTumor Necrosis Factor Receptor-Associated Peptides and Proteins

Autor:innen und Institutionen

  • Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Pediatric Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Qian Wang, Ivy John, Marcus Malek

Zitieren

APA

Torres, S., High, Z., Wang, Q., Piper, C., Friehling, E., Feingold, B., John, I., Malek, M., Ganoza, A., Skaugen, J. M., & Gestrich, C. K. (2025). TRAF7 ‐Mutated Myxoid and Spindle Cell Mesenchymal Tumor Occurring in a Pediatric Patient in the Post‐Transplant Setting: Expanding the Spectrum of TRAF7 ‐Mutated Tumors. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.70092

Vancouver

Torres S, High Z, Wang Q, Piper C, Friehling E, Feingold B, et al. TRAF7 ‐Mutated Myxoid and Spindle Cell Mesenchymal Tumor Occurring in a Pediatric Patient in the Post‐Transplant Setting: Expanding the Spectrum of TRAF7 ‐Mutated Tumors. Genes, Chromosomes and Cancer. 2025. doi:10.1002/gcc.70092

BibTeX
@article{Torres2025,
  author = {Torres, Stephanie and High, Zachary and Wang, Qian and Piper, Clinton and Friehling, Erika and Feingold, Brian and John, Ivy and Malek, Marcus and Ganoza, Armando and Skaugen, John M and Gestrich, Catherine K},
  title = {TRAF7 ‐Mutated Myxoid and Spindle Cell Mesenchymal Tumor Occurring in a Pediatric Patient in the Post‐Transplant Setting: Expanding the Spectrum of TRAF7 ‐Mutated Tumors},
  journal = {Genes, Chromosomes and Cancer},
  year = {2025},
  doi = {10.1002/gcc.70092}
}
Kostenlos starten →